Psycho-neurological syndrome which is driver’s health status plays a crucial role in ensuring road traffic safety.GoalThe study aims to determine factors leading to traffic accidents by assessing psycho-neurological status of drivers who caused road traffic accidents.MethodsIt is a double-randomized and cross-sectional study. Drivers caused the traffic accidents in the territory of Bayanzurkh District of Ulaanbaatar city between September 2011 and May 2012 were involved.Following investigations were done:• Thorough neurological examination using a prepared clinical pathway;• EEG test;• Assessment of attention, memory, intellectual speed and anxiety of drivers using Lusher test and computer based test.SPSS 18 was applied in data analysis and chi square test was applied in differentiation the proportions.ResultsThe male-female ratio among 394 drivers was 61.9% and 38.1% respectively. 322 drivers (89.04%) had symptoms of episodic headache, dizziness, blurred vision and unsteadiness. 60 drivers (15.2%) had nystagmus which is the main symptom of vertigo (p<0.001). 159 (40.9%) drivers experienced an insomnia. Epileptic and nonepileptic seizure was observed in 155 cases. Out of 394 drivers 243 (61.6%) had symptoms of anxiety. It was observed that 64.6% had low level of anxiety, 27.9% had medium, 7% had high level and 0.4% had severe anxiety. According to the Shultz table, we found that 46.4% of drivers were disintegrated attention and 12.4% (49) were with slow intellectual speed. The hypomnesia was 27.4% (108).Conclusions:1. According to our study, anxiety is dominated among the drivers and attention is disintegrated and slow.2. EEG results (abnormal II and III) proved that drivers who have epileptic and nonepileptic seizures are involved in the traffic accidents.3. Recurrent neurological conditions like headache, dizziness, insomnia, blurred vision and unsteadiness are preconditions for attention dispel, slowing of attention distribution and anxiety of drivers who caused traffic accidents and those recurrent neurological conditions are prevalent among drivers.

Background: Thrombocytopenia is more commonly observed in neonates compared to other age groups, occurring in 1-5% of healthy newborns. However, the incidence of thrombocytopenia is significantly higher (22%-35%) in sick neonates admitted to the Neonatal Intensive Care Unit (NICU), and numerous researchers have noted that severe thrombocytopenia contributes to neonatal mortality. However, the incidence of thrombocytopenia and mortality risk among patients in the NICU in our country has not yet been studied, which provided the rationale for our research. Aim: To investigate and determine the incidence of thrombocytopenia and the risk of mortality in neonates treated in the intensive care unit. Materials and Methods: Data were collected from the medical histories of infants hospitalized in the Neonatal Intensive Care Unit of the National Center for Maternal and Child Health in 2017-2019, and statistical processing was performed using the STATA 16 program. Results: Of all infants in our study, 56.53% (658) were boys and 43.47% (506) were girls. According to the gestational age of newborns, 34.19% (398) were full-term (>37 weeks), 61% (710) were preterm (28-36 weeks), and 4.81% (56) were extremely preterm (<28 weeks). According to birth weight, 33.65% (386) had low birth weight (2500g-1500g), 20.05% (230) had very low birth weight (1500g-1000g), and 8.81% (101) had extremely low birth weight (<1000g). Among the surveyed newborns, 534 (45.88%) had thrombocytopenia, and the number was 51.55% (200/388) in 2017, 46.15% (162/351) in 2018, and 40.47% (172/425) in 2019. The mean platelet count of newborns with thrombocytopenia was 50.21±43.23. Early (age <72 hours) 23.41% (125), late (age ≥72 hours) 76.59% (409), light platelet count (100-150x109/l) 17.42% (93), medium (50) -99x109/l) was 25.28% (135) and severe (<50x109/l) was 57.3% (306). The duration of thrombocytopenia in these infants was 13.68±10.33 days, and 72.65% (388) of them had thrombocytopenia, 27.15% (145) died without thrombocytopenia, and 0.18% (1) had autoimmune thrombocytopenia was under medical supervision and was discharged from the hospital. A total of 20.5% (239) of the neonates included in the study died, and among them, 76.15% (182) had thrombocytopenia, which showed a statistically significant difference when compared between the deceased and surviving groups (p<0.001). To determine whether neonatal thrombocytopenia is a risk factor for mortality, a univariate logistic regression analysis was performed, showing that thrombocytopenia increases the risk of mortality with an OR of 5.19 (p<0.001, 95% CI: 3.75-7.19). A multivariate logistic regression analysis further confirmed this association, with an OR of 2.46 (p<0.001, 95% CI: 1.65-3.68), indicating that neonatal thrombocytopenia significantly increases the risk of mortality. Conclusion Thrombocytopenia is commonly observed in neonates treated in the neonatal intensive care unit. Neonatal thrombocytopenia increases the risk of neonatal mortality.